ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 83 filers reported holding ONCOMED PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $5,000 | -64.3% | 1,500 | 0.0% | 0.00% | – |
| Q1 2017 | $14,000 | +16.7% | 1,500 | 0.0% | 0.00% | – |
| Q4 2016 | $12,000 | -29.4% | 1,500 | 0.0% | 0.00% | – |
| Q3 2016 | $17,000 | -5.6% | 1,500 | 0.0% | 0.00% | – |
| Q2 2016 | $18,000 | +20.0% | 1,500 | 0.0% | 0.00% | – |
| Q1 2016 | $15,000 | -87.0% | 1,500 | -70.5% | 0.00% | – |
| Q4 2015 | $115,000 | +38.6% | 5,087 | +1.5% | 0.00% | – |
| Q3 2015 | $83,000 | +29.7% | 5,014 | +75.3% | 0.00% | – |
| Q2 2015 | $64,000 | +100.0% | 2,861 | +133.7% | 0.00% | – |
| Q1 2015 | $32,000 | – | 1,224 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,108,815 | $4,273,000 | 0.48% |
| Birchview Capital, LP | 372,557 | $387,000 | 0.24% |
| Perceptive Advisors | 1,719,111 | $1,787,000 | 0.05% |
| Fondren Management LP | 25,136 | $26,000 | 0.02% |
| Cannell & Co. | 281,983 | $293,000 | 0.01% |
| APPLETON PARTNERS INC/MA | 66,206 | $69,000 | 0.01% |
| Quinn Opportunity Partners LLC | 66,162 | $69,000 | 0.01% |
| NJ State Employees Deferred Compensation Plan | 38,000 | $40,000 | 0.01% |
| Candriam S.C.A. | 380,000 | $395,000 | 0.01% |
| PRIMECAP MANAGEMENT CO/CA/ | 5,451,400 | $5,669,000 | 0.00% |